Table 1.
Age, years | 71 [37-93] |
Male gender | 67 (80.7) |
Child-Pugh score | |
<6 | 64 (77.1) |
=7 a | 16 (19.3) |
Main etiology of liver disease | |
Alcohol | 34 (41) |
HCV | 27 (32.5) |
HBV-HDV | 11 (13) |
NASH | 7 (8.5) |
Hemochromatosis | 4 (5) |
Esophageal varices | 36 (43.5) |
Platelet count, g/L | 149 [53-440] |
Platelet count <100 g/L | 22 (26.5) |
Prothrombin activity, % | 79 [42-100] |
Prothrombin activity <75% | 30 (36) |
Serum bilirubin level, μπιοI/L | 16 [4-78] |
Bilirubin >20 μπιI/L | 15 (18.1) |
Naive | 74 (89.1) |
Nonnaive | 9 (8.9%) |
Serum AFP level, ng/mL | 1,404 [1-60,500] |
AFP >200 ng/mL | 18 (21.7) |
Tumor | |
Mass forming | 61 (73.5) |
Infiltrative | 22 (26.5) |
Portal invasion at imaging | 12 (14.5) b |
Diameter of the main tumor, mm | 62 [51-90] |
Tumor diameter >70 mm | 22 (26.5) |
Number of tumors/patient | |
1 | 62 (74.7) |
2 | 17 (20.5) |
3 | 4 (4.8) |
Intrahepatic portal vein invasion | 12 (14.5) |
Data are presented as mean [range] or n (%). HCC, hepatocellular carcinoma; RFA, radiofrequency ablation; HCV, hepatitis C virus; HBV, hepatitis B virus; HDV, hepatitis D virus; NASH, nonalcoholic steatosic hepatitis; AFP, alpha-fetoprotein; BCLC, Barcelona Clinic Liver Cancer.
Excluded 3 patients without established cirrhosis.
Of which 10 were infiltrative forms.